title: Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.
abstract: OBJECTIVE
  To provide updated estimates of Alzheimer disease (AD) dementia prevalence in the United States from 2010 through 2050.
  
  
  METHODS
  Probabilities of AD dementia incidence were calculated from a longitudinal, population-based study including substantial numbers of both black and white participants. Incidence probabilities for single year of age, race, and level of education were calculated using weighted logistic regression and AD dementia diagnosis from 2,577 detailed clinical evaluations of 1,913 people obtained from stratified random samples of previously disease-free individuals in a population of 10,800. These were combined with US mortality, education, and new US Census Bureau estimates of current and future population to estimate current and future numbers of people with AD dementia in the United States.
  
  
  RESULTS
  We estimated that in 2010, there were 4.7 million individuals aged 65 years or older with AD dementia (95% confidence interval [CI] = 4.0-5.5). Of these, 0.7 million (95% CI = 0.4-0.9) were between 65 and 74 years, 2.3 million were between 75 and 84 years (95% CI = 1.7-2.9), and 1.8 million were 85 years or older (95% CI = 1.4-2.2). The total number of people with AD dementia in 2050 is projected to be 13.8 million, with 7.0 million aged 85 years or older.
  
  
  CONCLUSIONS
  The number of people in the United States with AD dementia will increase dramatically in the next 40 years unless preventive measures are developed.
authors: Rush Institute for Healthy Aging, Chicago, IL, USA. liesi_hebert@rush.edu
authors: Liesi E
authors: LE
authors: Hebert
authors: Jennifer
authors: J
authors: Weuve
authors: Paul A
authors: PA
authors: Scherr
authors: Denis A
authors: DA
authors: Evans
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000453:epidemiology*; D019352:Censuses; D005260:Female; D005544:Forecasting; D006801:Humans; D015994:Incidence; D008137:Longitudinal Studies; D008297:Male; D011159:Population Surveillance / Q000379:methods*; D014481:United States / Q000453:epidemiology
references: Neurology. 1988 Jun;38(6):975-80
references: 3368079
references: Neurology. 2000 Jun 13;54(11):2072-7
references: 10851365
references: Arch Neurol. 2003 Aug;60(8):1119-22
references: 12925369
references: JAMA. 1995 May 3;273(17):1354-9
references: 7715060
references: Neurology. 1984 Jul;34(7):939-44
references: 6610841
references: Milbank Q. 1990;68(2):267-89
references: 2233632
references: Am J Public Health. 1998 Sep;88(9):1337-42
references: 9736873
references: Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):306-14
references: 19568149
references: J Alzheimers Dis. 2003 Oct;5(5):349-55
references: 14646025
references: Natl Vital Stat Rep. 2016 Nov;65(8):1-65
references: 27906644
references: Neuroepidemiology. 2007;29(1-2):125-32
references: 17975326
references: Alzheimers Dement. 2011 Jan;7(1):61-73
references: 21255744
references: Neurology. 1993 Mar;43(3 Pt 1):515-9
references: 8450993
references: Arch Neurol. 2003 Feb;60(2):185-9
references: 12580702
references: Alzheimers Dement. 2011 Jan;7(1):74-9
references: 21255745